Reference
Ciani O, et al. An Economic Perspective on Urinary Tract Infection: The "Costs of Resignation". Clinical Drug Investigation : 9 Mar 2013. Available from: URL: http://dx.doi.org/10.1007/s40261-013-0069-x
Rights and permissions
About this article
Cite this article
UTIs have high economic and QOL burden. PharmacoEcon Outcomes News 674, 9 (2013). https://doi.org/10.1007/s40274-013-0254-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0254-4